Disclosures for "A Semi-Automated Tracking System for Monitoring Treatment with Novel Anti-amyloid Therapies"
-
Mr. Saukkonen has nothing to disclose.
-
Ms. Karwa has nothing to disclose.
-
Ms. Maimonis has nothing to disclose.
-
Dr. Dickson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for I-Mab Biopharma.
-
The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
-
Dr. Daffner has received personal compensation in the range of $0-$499 for serving as a Consultant for Elsivier. Dr. Daffner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Patterson, Belkap, Webb & Tyler. Dr. Daffner has received personal compensation in the range of $0-$499 for serving as a Consultant for Harvard University. Dr. Daffner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Wyatt Law. Dr. Daffner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Langfitt Garner PLLC. Dr. Daffner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Locks Law Firm. Dr. Daffner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakstone Publishing.
-
Author has nothing to disclose
-
Dr. Erkkinen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.